ELI LILLY & CO COM (LLY) : Weatherly Asset Management L. P. scooped up 275 additional shares in ELI LILLY & CO COM during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 337,882 shares of ELI LILLY & CO COM which is valued at $26,297,356.ELI LILLY & CO COM makes up approximately 8.95% of Weatherly Asset Management L. P.’s portfolio.
ELI LILLY & CO COM opened for trading at $76.52 and hit $77.16 on the upside on Wednesday, eventually ending the session at $76.51, with a gain of 0.31% or 0.24 points. The heightened volatility saw the trading volume jump to 36,90,949 shares. Company has a market cap of $84,627 M.
Other Hedge Funds, Including , Seaward Management Limited Partnership reduced its stake in LLY by selling 100 shares or 2.08% in the most recent quarter. The Hedge Fund company now holds 4,716 shares of LLY which is valued at $367,046. ELI LILLY & CO COM makes up approx 0.02% of Seaward Management Limited Partnership’s portfolio. Donald L. Hagan added LLY to its portfolio by purchasing 1,120 company shares during the most recent quarter which is valued at $84,594. ELI LILLY & CO COM makes up approx 0.08% of Donald L. Hagan’s portfolio.Palisade Asset Management boosted its stake in LLY in the latest quarter, The investment management firm added 830 additional shares and now holds a total of 21,959 shares of ELI LILLY & CO COM which is valued at $1,658,563. ELI LILLY & CO COM makes up approx 0.32% of Palisade Asset Management’s portfolio.Benjamin F. Edwards Company boosted its stake in LLY in the latest quarter, The investment management firm added 169 additional shares and now holds a total of 3,274 shares of ELI LILLY & CO COM which is valued at $247,285. ELI LILLY & CO COM makes up approx 0.05% of Benjamin F. Edwards Company’s portfolio.Jlb Associates Inc reduced its stake in LLY by selling 400 shares or 1.29% in the most recent quarter. The Hedge Fund company now holds 30,630 shares of LLY which is valued at $2,265,089. ELI LILLY & CO COM makes up approx 0.67% of Jlb Associates Inc’s portfolio.
On the company’s financial health, ELI LILLY & CO COM reported $0.83 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on Apr 26, 2016. Analyst had a consensus of $0.85. The company had revenue of $4865.10 million for the quarter, compared to analysts expectations of $4829.37 million. The company’s revenue was up 4.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.87 EPS.
Many Wall Street Analysts have commented on ELI LILLY & CO COM. Societe Generale Initiated ELI LILLY & CO COM on Apr 6, 2016 to “Hold”, Price Target of the shares are set at $78.
Eli Lilly and Company (Lilly) is engaged in drug manufacturing business. The Company discovers develops manufactures and market products in two segments: human pharmaceutical products and animal health products. The Company’s products are sold in approximately 120 countries. The Company’s human pharmaceutical business segment sells medicines which are discovered or developed by its scientists. Its animal health business segment operates through the Company’s Elanco division which develops manufactures and markets products for both food animals and companion animals. The Company manufactures and distributes its products through facilities in the United States Puerto Rico and 11 other countries. Its products include endocrinology products neuroscience products oncology products cardiovascular products products for food animals products for companion animals and Novartis AH products.